MARIA TERESA ABREU

Summary

Affiliation: University of Miami
Country: USA

Publications

  1. pmc TLR4 activates the β-catenin pathway to cause intestinal neoplasia
    Rebeca Santaolalla
    Division of Gastroenterology, Department of Medicine, University of Miami, Leonard Miller School of Medicine, Miami, Florida, USA
    PLoS ONE 8:e63298. 2013
  2. pmc Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study
    Inga Peter
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029 USA
    BMC Med Genet 12:63. 2011
  3. pmc The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia
    Yasmin Hernandez
    Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA
    BMC Gastroenterol 10:82. 2010
  4. doi request reprint Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study
    Maria T Abreu
    University of Miami Miller School of Medicine, Miami, FL 33101 6960, USA
    Inflamm Bowel Dis 15:829-36. 2009
  5. doi request reprint Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function
    Maria T Abreu
    Division of Gastroenterology, University of Miami Miller School of Medicine, P O Box 016960 D 49, Miami, Florida 33101, USA
    Nat Rev Immunol 10:131-44. 2010

Research Grants

Collaborators

  • William J Sandborn
  • Gert Van Assche
  • Emil Bisaccia
  • Christian Von Tirpitz
  • Thomas Ochsenkuhn
  • Stephen Hanauer
  • Rebeca Santaolalla
  • Masayuki Fukata
  • Cristhine Pastorini
  • John Sotolongo
  • Inga Peter
  • Yasmin Hernandez
  • Jeffrey Ko
  • Ramanarao Dirisina
  • Sakhi Philip
  • Cecilia L España
  • Oname Burlingame
  • Limin Shang
  • Mansoor M Ahmed
  • Daniel A Sussman
  • Sergio A Lira
  • Julie M Davies
  • Jose R Ruiz
  • Terrence A Barrett
  • Pablo A Bejarano
  • Keith Benkov
  • David Sachar
  • Barry Jaffin
  • Robert J Desnick
  • Laurie Ozelius
  • Thomas Ullman
  • Burton I Korelitz
  • James Aisenberg
  • Steven Itzkowitz
  • Adele A Mitchell
  • Anthony Weiss
  • Jianzhong Hu
  • Joel Bauer
  • Monica Erazo
  • Daniel H Present
  • Arthur Kornbluth
  • Simon Lichtiger
  • Peter Rubin
  • Dana Doheny
  • Lloyd Mayer
  • Daisy Conduah
  • Anli Chen
  • Keith Breglio
  • Lory A Hayes
  • Ryan Ungaro
  • David Hsu
  • Ruliang Xu

Detail Information

Publications5

  1. pmc TLR4 activates the β-catenin pathway to cause intestinal neoplasia
    Rebeca Santaolalla
    Division of Gastroenterology, Department of Medicine, University of Miami, Leonard Miller School of Medicine, Miami, Florida, USA
    PLoS ONE 8:e63298. 2013
    ..Our studies highlight a previously unexplored link between innate immune signaling and activation of oncogenic pathways, which may be targeted to prevent or treat CRC...
  2. pmc Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study
    Inga Peter
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029 USA
    BMC Med Genet 12:63. 2011
    ..We evaluated a set of well-established CD-susceptibility variants to determine if they can explain the increased CD risk in the AJ population...
  3. pmc The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia
    Yasmin Hernandez
    Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA
    BMC Gastroenterol 10:82. 2010
    ....
  4. doi request reprint Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study
    Maria T Abreu
    University of Miami Miller School of Medicine, Miami, FL 33101 6960, USA
    Inflamm Bowel Dis 15:829-36. 2009
    ..A prospective, uncontrolled pilot study was conducted to evaluate the safety and efficacy of ECP in patients with active Crohn's disease (CD) who were refractory to or intolerant of immunosuppressants and/or anti-TNF therapies...
  5. doi request reprint Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function
    Maria T Abreu
    Division of Gastroenterology, University of Miami Miller School of Medicine, P O Box 016960 D 49, Miami, Florida 33101, USA
    Nat Rev Immunol 10:131-44. 2010
    ..Thus, dysregulated TLR signalling by intestinal epithelial cells may explain how colonic bacteria and inflammation promote colorectal cancer...

Research Grants10

  1. Toll-Like Receptor-Complex in Intestinal Epith. Cells
    Maria Abreu; Fiscal Year: 2003
    ..The results of our studies have important implications for understanding host-microbial interactions and the inter-relationship between the innate and adaptive immune systems in the gut. ..
  2. Role of TLR4 in colitis-associated neoplasia
    MARIA TERESA ABREU; Fiscal Year: 2010
    ..With the support of this grant we can examine how TLR4 contributes to the development of colon cancer and try to prevent colon cancer by blocking TLR4. ..
  3. Toll-Like Receptor-Complex in Intestinal Epith. Cells
    Maria Abreu; Fiscal Year: 2007
    ..The results of our studies have important implications for understanding host-microbial interactions and the inter-relationship between the innate and adaptive immune systems in the gut. ..
  4. Toll-Like Receptor-Complex in Intestinal Epith. Cells
    Maria Abreu; Fiscal Year: 2006
    ..The results of our studies have important implications for understanding host-microbial interactions and the inter-relationship between the innate and adaptive immune systems in the gut. ..
  5. Role of TLR4 in colitis-associated neoplasia
    MARIA TERESA ABREU; Fiscal Year: 2011
    ..With the support of this grant we can examine how TLR4 contributes to the development of colon cancer and try to prevent colon cancer by blocking TLR4. ..